Eric Van der Putten, Modra Pharmaceuticals - Oral Taxane Therapy | LSI Europe '24

Developing oral taxane therapies with fewer severe side effects to improve cancer patients' lives.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Eric van
Eric van
Chief Business Officer, Modra Pharmaceuticals